NYU Langone Faces Federal Criminal Subpoena Over Transgender Youth Healthcare
NYU Langone Health was served a federal grand jury subpoena over transgender care for minors on May 7, 2026.
Why it matters: Legal and compliance officers, especially general counsel managing healthcare data, now face a complex scenario: protecting patient privacy while addressing a criminal inquiry regarding gender-affirming care for minors, amid shifting federal and state regulations.
- On May 7, 2026, NYU Langone Health received a federal grand jury subpoena for records on care to minors identifying as transgender.
- This marks the first public acknowledgment of a hospital facing a criminal probe for gender-affirming care.
- The subpoena seeks patient and provider data for services between 2020 and 2026; New York’s Shield Law requires 30-day notice to affected patients before disclosure.
- NYU Langone closed its program providing care to transgender youth in February 2026 amid regulatory scrutiny and leadership changes.
NYU Langone Health has acknowledged being served a federal grand jury subpoena on May 7, 2026, by the U.S. Attorney's Office in the Northern District of Texas. The criminal inquiry centers on records for minors under 18 who received gender-affirming healthcare—such as hormone therapy or counseling—between 2020 and 2026, as well as information about the providers.
- This is the first known federal criminal subpoena to a hospital system over gender-affirming care. Previously, more than 20 civil subpoenas were sent to individual clinics and doctors, but no hospital systems had publicly reported a criminal investigation of this type.
- NYU Langone ended its Transgender Youth Health Program, which provided medical and psychosocial support to transgender minors and their families, in February 2026 due to increasing regulatory pressures and staff departures as outlined by the hospital.
- Federal inquiry into such care gained momentum after a January 2025 executive order directed agencies to use federal funding and enforcement levers to restrict gender-affirming healthcare for those under 19. (The order is referenced in media reports.)
- In compliance with New York’s Shield Law, NYU Langone must provide affected patients at least 30 days’ notice before responding to the subpoena with any protected health information.
- The legal context is deeply fragmented: 27 states have enacted laws limiting access to gender-affirming care for minors, while some states, including New York, provide statutory protections for such care, creating sharply divergent compliance environments.
- Leading medical groups, including the American Academy of Pediatrics, regard gender-affirming care as vital for some youth with gender dysphoria—offering guidance for general counsel and compliance officers on navigating medical standards versus regulatory demands in this area.
Advocacy organizations warn of risks to provider confidentiality and patient privacy. Tyler Hack of the Christopher Street Project (May 2026) described the probe as "an attack on privacy in healthcare for all Americans." Laurel Powell, Human Rights Campaign spokesperson (May 2026), cited a "shocking escalation" of legal scrutiny targeting care delivery.
By the numbers:
- 27 — Number of states with laws restricting or banning gender-affirming care for minors
- 30 — Minimum days’ notice NYU Langone must give patients before complying with a subpoena under New York law
- 2020–2026 — Period for which patient and provider records are sought by federal prosecutors
Yes, but: New York’s Shield Law grants significant procedural safeguards for providers and patients, but the enforcement approach taken by federal authorities is likely to trigger further legal challenges and uncertainty for institutions operating across state lines.
What's next: Healthcare legal teams at major hospitals and clinics across the U.S. are closely monitoring the case and preparing for potential additional subpoenas as federal enforcement evolves.